JP2025500347A5 - - Google Patents
Info
- Publication number
- JP2025500347A5 JP2025500347A5 JP2024537381A JP2024537381A JP2025500347A5 JP 2025500347 A5 JP2025500347 A5 JP 2025500347A5 JP 2024537381 A JP2024537381 A JP 2024537381A JP 2024537381 A JP2024537381 A JP 2024537381A JP 2025500347 A5 JP2025500347 A5 JP 2025500347A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- polypeptide
- aav
- disease
- mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163252559P | 2021-10-05 | 2021-10-05 | |
| US63/252,559 | 2021-10-05 | ||
| PCT/US2022/077628 WO2023060142A2 (en) | 2021-10-05 | 2022-10-05 | Engineered cardiac muscle compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500347A JP2025500347A (ja) | 2025-01-09 |
| JP2025500347A5 true JP2025500347A5 (cg-RX-API-DMAC7.html) | 2025-10-15 |
Family
ID=85803752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537381A Pending JP2025500347A (ja) | 2021-10-05 | 2022-10-05 | 操作された心筋組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240409956A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4413025A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025500347A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118339176A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022360985A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3236534A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023060142A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3210955A1 (en) * | 2021-02-09 | 2022-08-18 | Affinia Therapeutics Inc. | Recombinant aavs with improved tropism and specificity |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| WO2025024254A2 (en) * | 2023-07-21 | 2025-01-30 | The Trustees Of Indiana University | Aav vector formulation |
| EP4766844A1 (en) * | 2023-08-25 | 2026-07-01 | Agency for Science, Technology And Research | COMPOSITION AND METHODS FOR IDENTIFYING NEW AAV VARIANTS FOR ADMINISTRATING DIFFERENTIATED GENES TO CARDIOMYOCTS AND/OR SKELETAL MYOFIBERS |
| WO2025160155A1 (en) | 2024-01-22 | 2025-07-31 | The Broad Institute, Inc. | Epigenetic targeting of prion diseases |
| WO2026006391A1 (en) * | 2024-06-25 | 2026-01-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Compositions and methods for treating a heart disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7314974B2 (en) * | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
| WO2006092449A2 (en) * | 2005-03-02 | 2006-09-08 | Metanomics Gmbh | Process for the production of fine chemicals |
| AU2016366549B2 (en) * | 2015-12-11 | 2022-11-10 | California Institute Of Technology | Targeting peptides for directing adeno-associated viruses (AAVs) |
| DK3684423T5 (da) * | 2017-09-20 | 2024-08-26 | 4D Molecular Therapeutics Inc | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf |
| US11149256B2 (en) * | 2018-09-26 | 2021-10-19 | California Institute Of Technology | Adeno-associated virus compositions for targeted gene therapy |
| EP3883591B1 (en) * | 2018-11-20 | 2024-11-13 | Universität Heidelberg | Relaxin receptor 1 for use in treatment and prevention of heart failure |
| US20220325296A1 (en) * | 2019-09-12 | 2022-10-13 | The Broad Institute, Inc. | Engineered adeno-associated virus capsids |
| JP2022551986A (ja) * | 2019-10-16 | 2022-12-14 | ザ・ブロード・インスティテュート・インコーポレイテッド | 修飾筋肉標的化組成物 |
| EP3868875A1 (en) * | 2020-02-20 | 2021-08-25 | Medizinische Hochschule Hannover | Viral vector particle based on aav2 for gene therapy |
-
2022
- 2022-10-05 JP JP2024537381A patent/JP2025500347A/ja active Pending
- 2022-10-05 US US18/698,929 patent/US20240409956A1/en active Pending
- 2022-10-05 EP EP22879462.4A patent/EP4413025A4/en active Pending
- 2022-10-05 CA CA3236534A patent/CA3236534A1/en active Pending
- 2022-10-05 WO PCT/US2022/077628 patent/WO2023060142A2/en not_active Ceased
- 2022-10-05 CN CN202280079514.3A patent/CN118339176A/zh active Pending
- 2022-10-05 AU AU2022360985A patent/AU2022360985A1/en active Pending